Yes relatively: Abilify (aripiprazole) was approved in 2002. Fda indications include: schizophrenia, acute manic and mixed episodes associated with bipolar disorder; an adjunct for the treatment of major depressive disorder; to treat irritability in children with autism. It is a Dopamine receptor partial agonist, which makes it unique compared to prior medications (even relatively new ones) for schizophrenia.
Answered 10/4/2016
5.6k views
7 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question